Article info
Background
Paper
How to keep high-risk studies ethical: classifying candidate solutions
- Correspondence to Professor Nir Eyal, Department of Global Health and Population, Harvard TH Chan School of Public Health, Harvard University, 02115 Boston, MA, USA; neyal{at}hsph.harvard.edu
Citation
How to keep high-risk studies ethical: classifying candidate solutions
Publication history
- Received February 1, 2016
- Accepted February 18, 2016
- First published June 9, 2016.
Online issue publication
January 25, 2017
Article Versions
- Previous version (9 June 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Other content recommended for you
- The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction
- When to start paediatric testing of the adult HIV cure research agenda?
- Comparison of efficacy discrepancy between early-phase clinical trials and phase III trials of PD-1/PD-L1 inhibitors
- Informed consent to HIV cure research
- Why cure, why now?
- Individual risk and community benefit in international research
- First-in-human HIV-remission studies: reducing and justifying risk
- Assessing research risks systematically: the net risks test
- Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment
- Cure research and consent: the Mississippi Baby, Barney Clark, Baby Fae and Martin Delaney